| A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux (NCT05192538) | Affiliated Hospital to Academy of Military Medical Sciences | 2022-02-10 |
| The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis (NCT05813561) | Daewoong Pharmaceutical Co. LTD. | 2021-12-30 |
| The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis (NCT07079540) | Jiangsu Sinorda Biomedicine Co., Ltd | 2021-06-24 |
| Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy (NCT04657848) | Zhejiang Cancer Hospital | 2020-06-01 |
| Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux Esophagitis (NCT04531475) | Jiangsu Sinorda Biomedicine Co., Ltd | 2020-01-21 |
| A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer (NCT03553563) | AstraZeneca | 2018-07-24 |
| Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's Oesophagus (NCT03388047) | University of Cambridge | 2018-01-01 |
| Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation (NCT03116841) | Takeda | 2017-08-02 |
| Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use" (NCT03214081) | Takeda | 2016-03-01 |
| Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome (NCT02513784) | Columbia University | 2015-08-01 |
| Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes (NCT02477475) | AstraZeneca | 2015-07-07 |
| Double Tract Anastomosis and Gastric Tube Anastomosis to Proximal Gastrectomy (NCT02288728) | Jian-Kun Hu | 2014-12-01 |
| BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects (NCT01964131) | AstraZeneca | 2013-10-01 |
| The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD (NCT01860482) | Chong Kun Dang Pharmaceutical | 2013-04-01 |
| The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis (NCT01733810) | Dallas VA Medical Center | 2013-02-01 |
| Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis (NCT01538849) | Yuhan Corporation | 2012-12-01 |
| Adipokines and the Risk of Reflux Esophagitis (NCT01560598) | Seoul National University Hospital | 2012-06-01 |
| To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole (NCT01397084) | AstraZeneca | 2011-08-01 |
| Incidence of Reflux Esophagitis After Pancreaticoduodenectomy (NCT01311908) | National Taiwan University Hospital | 2011-03-01 |
| The Efficacy of i-Scan for Detecting Reflux Esophagitis (NCT01381991) | Konkuk University Hospital | 2010-07-01 |
| Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis (NCT00586963) | Mayo Clinic | 2008-01-01 |
| Reflux Esophagitis Phase III Study (Initial Treatment) (NCT00633932) | AstraZeneca | 2007-12-01 |
| Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis (NCT00859287) | AstraZeneca | 2007-06-01 |
| NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis (NCT00206180) | AstraZeneca | 2004-06-01 |
| Immunologic Factors in Reflux Esophagitis and Barrett's Esophagus (NCT00155805) | National Taiwan University Hospital | 2004-02-01 |
| 24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis (NCT00154570) | National Taiwan University Hospital | 2004-02-01 |